Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients

INTRODUCTION: The combination of lamivudine plus a protease inhibitor boosted with ritonavir (PI/r) has become an alternative as simplification strategy in HIV-infected patients with toxicity/intolerance to other nucleoside analogues (NA). Lamivudine plus darunavir/r (DRV/r) could be an adequate onc...

Descripción completa

Detalles Bibliográficos
Autores principales: Luis Casado, Jose, Bañón, Sara, Moreno, Ana, Diaz de Santiago, Alberto, Gomez, Cristina, Perez-Elías, María J, Moreno, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P269
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225277/
https://www.ncbi.nlm.nih.gov/pubmed/25397545
http://dx.doi.org/10.7448/IAS.17.4.19801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225277/
https://www.ncbi.nlm.nih.gov/pubmed/25397545
http://dx.doi.org/10.7448/IAS.17.4.19801

Ejemplares similares